Evidence map›Paper›PMID 34718565›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2022

Visual Impairment and Risk of Dementia in 2 Population-Based Prospective Cohorts: UK Biobank and EPIC-Norfolk.

Thomas J Littlejohns, Shabina Hayat, Robert Luben, Carol Brayne, Megan Conroy, Paul J Foster, Anthony P Khawaja, Elżbieta Kuźma

Open access · hybridAbstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Severity and progression of visual impairment and risk of dementia.Alzheimer's & dementia (Amsterdam, Netherlands)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Thomas J LittlejohnsNuffield Department of Population Health, University of Oxford, Oxford, UK.ORCID 0000-0003-1177-6923
Shabina HayatDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Robert LubenDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.ORCID 0000-0002-5088-6343
Carol BrayneDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.ORCID 0000-0001-5307-663X
Megan ConroyNuffield Department of Population Health, University of Oxford, Oxford, UK.
Paul J FosterNIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK.
Anthony P KhawajaNIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK.
Elżbieta KuźmaAlbertinen-Haus Centre for Geriatrics and Gerontology, University of Hamburg, Hamburg, Germany.
University of Cambridge · GBUniversity of Oxford · GBMoorfields Eye Hospital · GBUniversität Hamburg · DE

Funding

Cancer Research UK 14136Cancer Research UK 16896Cancer Research UK C864/A14136Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MC_PC_17228Medical Research Council MC_QA137853Medical Research Council MC_UU_12015/1Medical Research Council MR/N003284/1Medical Research Council MR/T040912/1
6 · The paper itself

Abstract

Visual impairment has emerged as a potential modifiable risk factor for dementia. However, there is a lack of large studies with objective measures of vision and with more than 10 years of follow-up. We investigated whether visual impairment is associated with an increased risk of incident dementia in UK Biobank and European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk). In both cohorts, visual acuity was measured using a "logarithm of the minimum angle of resolution" (LogMAR) chart and categorized as no (≤0.30 LogMAR), mild (>0.3 to ≤0.50 LogMAR), and moderate to severe (>0.50 LogMAR) impairment. Dementia was ascertained through linkage to electronic medical records. After restricting to those aged ≥60 years, without prevalent dementia and with eye measures available, the analytic samples consisted of 62 206 UK Biobank and 7 337 EPIC-Norfolk participants, respectively. In UK Biobank and EPIC-Norfolk, respectively, 1 113 and 517 participants developed dementia over 11 and 15 years of follow-up. Using multivariable Cox proportional-hazards models, the hazard ratios for mild and moderate to severe visual impairment were 1.26 (95% confidence interval [CI]: 0.92-1.72) and 2.16 (95% CI: 1.37-3.40), in UK Biobank, and 1.05 (95% CI: 0.72-1.53) and 1.93 (95% CI: 1.05-3.56) in EPIC-Norfolk, compared to no visual impairment. When excluding participants censored within 5 years of follow-up or with prevalent poor or fair self-reported health, the direction of the associations remained similar for moderate impairment but was not statistically significant. Our findings suggest visual impairment might be a promising target for dementia prevention; however, the possibility of reverse causation cannot be excluded.

Indexed as

DementiaNeoplasmsBiological Specimen BanksHumansProspective StudiesRisk FactorsUnited KingdomVision DisordersEpidemiologyLongitudinalPreventionVisual acuity

Identifiers

PMID34718565
PMCPMC8974347
OpenAlexW3208663502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.